BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Axxima Pharmaceuticals AG

Axxima™ Pharmaceuticals AG (formerly VirGene) is the leader in the application of pathogen-host signal transduction intervention. The company develops proprietary drugs that are based on Axxima's revolutionary approach to generate a Signal Transduction Firewall™ (STF™) against pathogens. Axxima's business strategy is to pursue the highly desirable area of anti-infective drug discovery from beginning to end, from target identification to drug development, making it a small pharmaceutical company rather than a traditional platform-based biotechnology startup. Axxima has developed a technology platform directed towards the identification of "critical" interaction points between a pathogen and target cells in the host. Axxima is developing small molecule drugs to interfere at these critical interaction points, thus blocking the pathogen's manipulation of the host cell and leaving the pathogen without the tools with which to establish itself in the host.


Contact Details:
Am Klopferspitz 19
Martinsried
Bavaria
D-82152
Germany
Tel:+49 (0) 89 - 740 165 - 0
Fax:+49 (0) 89 - 740 165 - 20
Email:
WWW:

www.axxima.com/




Recent Publications by Axxima Pharmaceuticals AG:

Advances in anti-viral therapeutics.
Hepatitis C virus (HCV) and HIV infections are of high economical...
14th April, 2006
Axxima Pharmaceuticals AG, Max-Lebsche-Platz 32, D-81377 Munich, Germany. Expert Opin Investig Drugs. 2005 Mar;14(3):343-8.
DOI Direct Link
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling.
Knowledge about molecular drug action is critical for the development of...
5th October, 2005
Axxima Pharmaceuticals AG, Munich, Germany. Cancer Res. 2005 Aug 1;65(15):6919-26.
DOI Direct Link
Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay.
The human cytomegalovirus (HCMV) protein kinase pUL97 represents an...
19th August, 2005
Axxima Pharmaceuticals AG, Munich, Germany. J Biomol Screen. 2005 Feb;10(1):36-45.
DOI Direct Link
Host cell targets in HCV therapy: novel strategy or proven practice?
The development of novel antiviral drugs against hepatitis C is a...
12th August, 2005
Axxima Pharmaceuticals Antivir Chem Chemother. 2005;16(2):69-90.
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.
Small molecule inhibitors belonging to the pyrido[2,3-d]pyrimidine class...
21st June, 2005
Axxima Pharmaceuticals AG, 81377 Munchen, Germany. Mol Cell Proteomics. 2004 Dec;3(12):1181-93. Epub 2004 Oct 8.
DOI Direct Link

View more Axxima Pharmaceuticals AG research publications.

BioNews Results for Axxima Pharmaceuticals AG:

BIOTECHNICA Promotes Dialogue on European Biotech Goals
Pharma Live:  Oct 5 2008 7:50AM Matching: pharmaceuticals ag
Pharma manufacturing: People on the move
LabTechnologist.com:  Oct 5 2008 6:32PM Matching: pharmaceuticals ag
Bayer s Novel Anticoagulant Xarelto Now Also Approved in the EU
Pharma Live:  Oct 4 2008 12:35AM Matching: pharmaceuticals ag
Bayer s Novel Anticoagulant Xarelto Now Also Approved in the EU
Drugs.com:  Oct 3 2008 7:33AM Matching: pharmaceuticals ag
Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
Calibre Macro World:  Oct 3 2008 1:44AM Matching: pharmaceuticals ag
Promote your company here: BioNewsCast - Press Release Distribution

View more Axxima Pharmaceuticals AG news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 414 times since April 2007, the link to the organisation's website has been followed 82 times

Recent Search Terms used to find this page: axxima | axxima pharmaceuticals tel | Axxima Pharmaceuticals AG | axxima pharmaceuticals tel | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals | t | .

Search for more companies in Martinsried

Search for more companies in Bavaria



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Axxima Pharmaceuticals AG
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.